Jan 30, 2025, 06:00
Advancing insights in metastatic renal cell carcinoma – International Urology Cancer Summit
International Urology Cancer Summit shared a post on LinkedIn about a recent paper by
” ‘Role of Hb to RDW ratio in metastatic RCC patients treated with first-line immunotherapy combinations’ explores a promising prognostic factor to improve patient counselling and guide treatment decisions.
Well done to all the authors.
Advancing insights in metastatic renal cell carcinoma!”
Authors: Matilde Corianò, Alessandro Lazzarini, Michele Maffezzoli, Alessio Signori, Sebastiano Buti et al.
More posts featuring International Urology Cancer Summit.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 30, 2025, 05:52
Jan 30, 2025, 05:49